We are developing a safe, cost-effective and comprehensive wound care dressing to prevent infections, and accelerate the healing of chronic wounds. We want to create a product which can be readily accessible for the medically underserved and socioeconomically disadvantaged members of our world.

Chronic wounds often take longer than three months to heal and sometimes may linger for years. This is due to repeated infections which can result in additional complications. These wounds are extremely dangerous to patients, especially those afflicted with diabetes, obesity or other immune conditions. These illnesses greatly increase the likelihood of acquiring chronic wounds. The most common types of chronic wounds are Venous Stasis Ulcers, Arterial Ulcers, Pressure Ulcers , and Diabetic Foot Ulcers.

There are 420 million diabetics worldwide

Approximately 15% or 63 million of them will develop a foot ulcer during their lifetime

Source: International Diabetes Federation

We are focusing our efforts on diabetic foot ulcers, especially for populaces without access to adequate products or treatments to protect these wounds. Our product targets the most important factors affecting wound healing:

  • Maintain Moist Healing Environment

  • Remove Dead Tissue

  • Oxygenate Wound

  • Trap and Kill Pathogens

  • Control Exudate (Blood and Plasma)

  • Be Comfortable

  • Be Durable

OUR MISSION

To design and deliver novel wound care technology inspired by patient needs.

 

© 2020 InMEDBio, LLC

  • Black Facebook Icon
  • Black LinkedIn Icon